The U.S. Department of Justice escalated its admissions enforcement by accusing Yale University’s medical school of illegally using race in admissions, alleging Black and Hispanic applicants had higher admission rates than white or Asian applicants with comparable academic metrics. The DOJ letter also seeks a voluntary resolution agreement and notes the agency can pursue court action if Yale does not comply. Yale said it is “confident” in its admissions process and plans to review the DOJ letter, adding that admitted students demonstrate exceptional achievement and commitment and that graduates go on to careers in clinical care, research, and public service. The case adds to a growing pattern of federal scrutiny aimed at universities since the 2023 Supreme Court decision banning race-conscious admissions in cases involving Harvard and the University of North Carolina. The administration has also signaled pressure on universities to stop using race as an admissions factor. The DOJ’s move matters for higher education compliance planning—especially for medical schools operating under Title VI and related civil-rights standards—because the allegations are tied to how institutions interpret and apply applicant selection criteria.